(Total Views: 401)
Posted On: 09/03/2019 1:35:53 PM
Post# of 72445
The only color the company provided with regard to the upfront payment is that it will "help cover substantially" the planned B-UC phase 2 trial.
Since that will be a trial with a pill and likely a phase 2a or small phase 2, it probably won't cost too much money. Probably in the range of $5-15 million.
Given those parameters, the upfront B-UP payment was likely $5-15M or less. If it was considerably more I would have expected verbage confirming that the B-UC trial would be completely covered along with some Kevetrin development expenses.
Just one man's opinion.
Since that will be a trial with a pill and likely a phase 2a or small phase 2, it probably won't cost too much money. Probably in the range of $5-15 million.
Given those parameters, the upfront B-UP payment was likely $5-15M or less. If it was considerably more I would have expected verbage confirming that the B-UC trial would be completely covered along with some Kevetrin development expenses.
Just one man's opinion.
(0)
(0)
